Look for:

Our offer for

BB BIOTECH AG CHF0.20 (REGD)


ISIN:
CH0038389992
WKN:
3838999

2024/06/24 15:57:28
Price
46.50 USD
Difference -2.72% (-1.30)

General attributes

ISINCH0038389992
SymbolBION
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)2,431 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open46.50 USD
High46.50 USD
Low46.50 USD
Close (prev. day)47.80 USD
VWAP46.50 USD
Volume (pcs)1,000
Trading volume46,500.00
Number of trades2
Last size500

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: BB BIOTECH AG CHF0.20 (REGD)PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/06/24 15:57:28
Price
46.50 USD
Difference -2.72% (-1.30)

General attributes

ISINCH0038389992
SymbolBION
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)2,431 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open46.50 USD
High46.50 USD
Low46.50 USD
Close (prev. day)47.80 USD
VWAP46.50 USD
Volume (pcs)1,000
Trading volume46,500.00
Number of trades2
Last size500

Performance and Risk

6m1Y3Y
Perf (%)---51.05%
Perf (abs.)---48.50
Beta0.380.570.92
Volatility100.56160.11114.06
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)- USD (-)
Ø price 30 days | Ø volume 30 days (pcs.)46.93 USD (34)
Ø price 100 days | Ø volume 100 days (pcs.)50.39 USD (37)
Ø price 250 days | Ø volume 250 days (pcs.)50.16 USD (52)
YTD High | date57.70 USD (2024/01/16)
YTD Low | date46.50 USD (2024/05/14)
52 Weeks High | date57.70 USD (2024/01/16)
52 Weeks Low | date43.65 USD (2023/10/04)

All listings for BB BIOTECH AG CHF0.20 (REGD)

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/07/1717:3544.55 EUR1.20171
SIX Swiss Exchange2024/07/1717:3043.20 CHF1.84228
London Stock Exchange European Trade Reporting2024/07/1717:2043.525 CHF0.002
Hanover2019/06/2808:1058.80 EUR0.002
Hamburg2019/06/2808:5559.50 EUR0.002
Frankfurt2024/07/1718:5444.70 EUR0.0520
FINRA other OTC Issues2024/06/2415:5746.50 USD0.052
Duesseldorf2019/06/2808:1058.75 EUR0.001
Berlin2019/07/0910:2159.55 EUR0.004

Company Logo

Contact Details

BB BIOTECH AG
- -
Schwertstrasse 6 - 8200 Schaffhausen
Telefon: +41-52-624-08-45
Fax: +
E-mail: info@bbbiotech.com

PDF Downloads

Company report: BB BIOTECH AG CHF0.20 (REGD)PDF Download

Company Profile

BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.

Members of Management Board

Daniel KollerMember of Executive Committee
Felicia FlaniganMember of Executive Committee

Board of directors

Clive MeanwellMember of the administrative board
Mads Krogsgaard ThomsenMember of the administrative board
Pearl Shirley HuangMember of the administrative board
Camilla SoenderbyMember of the administrative board
Laura HamillMember of the administrative board
Thomas von PlantaChairman of the administrative boar





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer